Compare ARK Genomic Revolution ETF (ARKG) vs Sea Limited (SE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Sea Limited — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Sea Limited trades at $111.9 (market cap $68.07B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Sea Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | SE | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $196.50 |
52-Week Low | $23.09 | $78.16 |
Market Cap | — | $68.07B |
Enterprise Value | — | $61.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Sea Limited (SE) trades at $111.14, up 1.86% on the day, near its resistance level of $112. The stock shows strong revenue growth, with 2025 revenue reaching $22.94 billion and net income of $1.58 billion, though recent quarterly earnings have been mixed. Technical indicators are bullish on moving averages but show overbought conditions with RSI above 78. Analyst sentiment remains positive with a consensus price target of $131.
Outlook: Growth prospects are supported by expanding digital services in Southeast Asia, but risks include competitive pressures and execution challenges. The stock's high P/E of 43.76 suggests premium valuation, requiring sustained earnings growth to justify current levels. Near-term performance may hinge on Q2 2026 earnings versus expectations of $0.834 EPS.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Sea Limited
Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.
Read more on SE →
